Fluconazole pharmacokinetics in burn patients.
نویسندگان
چکیده
The pharmacokinetics of fluconazole in nine adult patients with severe (30 to 95% total body surface area) burns were studied. There was no significant difference in half-life (t1/2), clearance (CL), or volume of distribution (V) over time in five patients on days 3 and 8 of the study (P > 0.05). Combined parameter estimates (means +/- standard deviations) for all nine patients for the two study periods were as follows: t1/2, 24.4 +/- 5.8 h; CL, 0.36 +/- 0.09 ml/min/kg; and V, 0.72 +/- 0.12 liters/kg. These estimates of t1/2 and CL in burn patients were approximately 13% shorter and 30% more rapid, respectively, than the most extreme estimates reported for other populations.
منابع مشابه
Clinical Pharmacology of Fluconazole in Neonates: Effects and Pharmacokinetics
Fluconazole is commonly used both to prevent and to treat invasive neonatal Candida albicans infection. This drug is a potent, selective, triazole inhibitor of the fungal enzymes involved in ergosterol synthesis. It is largely excreted unchanged in the urine. In infants with a birth weight
متن کاملThe pharmacokinetics of fluconazole after a single intravenous dose in AIDS patients.
The pharmacokinetics of fluconazole after a single 100 mg i.v. dose were studied in 10 healthy subjects (5 M; 5 F) and 10 HIV-positive patients (8 M; 2 F). The mean value of plasma clearance was 25% lower in the patient groups (17 +/- 6 (s.d.) vs 23 +/- 4 ml min-1; 95% CI of difference -11 to -0.7; P < 0.05). This difference may have been related to slightly reduced kidney function in the patie...
متن کاملEffect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a multiple-dose, three-period, placebo-controlled, crossover study. Patients were randomly assigned to receive indinavir at 1,000 mg every 8 h for 7 1/3 days (with fluconazole placebo), fluconazole at 400 mg ...
متن کاملEffect of Fluconazole on Indinavir Pharmacokinetics in Human Immunodeficiency Virus-Infected Patients
To evaluate a potential pharmacokinetic interaction of coadministration of fluconazole, and indinavir, a human immunodeficiency virus (HIV) protease inhibitor, 13 patients were enrolled in a multiple-dose, threeperiod, placebo-controlled, crossover study. Patients were randomly assigned to receive indinavir at 1,000 mg every 8 h for 71⁄3 days (with fluconazole placebo), fluconazole at 400 mg on...
متن کاملFluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients
I School of Pharmaceutical Sciences, Universidade de São Paulo São Paulo/ SP, Brazil II Servico de Terapia Intensiva, Hospital do Servidor Publico Estadual São Paulo/SP, Brazil III Plastic Surgery and Burns, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo São Paulo/SP, Brazil Email: [email protected] Tel.: 55 11 3069.2189 FLUCONAZOLE PLASMA CONCENTRATION MEASUREMENT BY...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Antimicrobial agents and chemotherapy
دوره 42 4 شماره
صفحات -
تاریخ انتشار 1998